TP53 and lung cancer: Given that primary lung cancer models provide a more accurate assessment of targeted therapeutic efficacy compared to nude mouse subcutaneous tumor models, we utilized lentivirus to overexpress the oncogene KRASG12D and silence the tumor suppressor gene TP53 in adult mice to induce tumor formation.